Younger T cells may improve immunotherapy for children's cancer

(Children's Hospital of Philadelphia) Pediatric oncologists have investigated techniques to improve and broaden a novel personalized cell therapy to treat children with cancer. The researchers say a patient's outcome may be improved if clinicians select specific subtypes of T cells to attack diseases like acute lymphoblastic leukemia and lymphoma.